Occult ovarian failure.
Healy
D L
DL
Department of Obstetrics and Gynaecology, Monash Medical Centre, Clayton, Victoria, Australia.
D002064:Buserelin / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D017273:Goserelin / Q000627:therapeutic use; D013006:Growth Hormone / Q000627:therapeutic use; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy* / Q000209:etiology; D016729:Leuprolide / Q000627:therapeutic use; D018587:Oocyte Donation; D011247:Pregnancy; D016649:Primary Ovarian Insufficiency / Q000188:drug therapy* / Q000503:physiopathology
D003276:Contraceptives, Oral; D006133:Growth Substances; D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone; D003907:Dexamethasone; D013006:Growth Hormone; D016729:Leuprolide; D002064:Buserelin